Individual holder
SEBTI SAID M
US·10 granted patents·2 pending applications·18 citations·filing 2006–2016
Individually held — no corporate assignee on record.
Top patents by PatentIndex Score
12 records- 0189US8642278B2Inhibition of cell proliferationSEBTI SAID M·Filed 2006·Granted Feb 4, 2014·7 cites·86 claims
- 0287US9597329B2Aurora kinase inhibitors and methods of making and using thereofSEBTI SAID M·Filed 2016·Granted Mar 21, 2017·4 cites·12 claims
- 0383US8691799B2Materials and methods for treatment of cancer and identification of anti-cancer compoundsSEBTI SAID M·Filed 2011·Granted Apr 8, 2014·2 cites·19 claims
- 0476US9453049B2Substrate-mimetic Akt inhibitorSEBTI SAID M·Filed 2014·Granted Sep 27, 2016·1 cites·13 claims
- 0576US8828451B2Akt sensitization of cancer cellsSEBTI SAID M·Filed 2007·Granted Sep 9, 2014·2 cites·5 claims
- 0676US8822524B2Substrate-mimetic Akt inhibitorSEBTI SAID M·Filed 2009·Granted Sep 2, 2014·1 cites·5 claims
- 0768US9249124B2Aurora kinase inhibitors and methods of making and using thereofSEBTI SAID M·Filed 2012·Granted Feb 2, 2016·1 cites·6 claims
- 0865US2007191490A1Withacnistin compounds for treatment of cancerSEBTI SAID M·Filed 2007·Application pending·0 cites
- 0961US8993760B2Rock inhibitors and uses thereofSEBTI SAID M·Filed 2009·Granted Mar 31, 2015·0 cites·7 claims
- 1057US2014296128A1Materials and methods for treatment of cancer and identification of anti-cancer compoundsSEBTI SAID M·Filed 2014·Application pending·0 cites
- 1155US10946012B2Methods for inducing tumor regression, inhibiting tumor growth, and inducing apoptosis in breast tumors with geranylgeranyltransferase I inhibitorsSEBTI SAID M·Filed 2011·Granted Mar 16, 2021·0 cites·4 claims
- 1253US8153596B2Use of SH2 STAT3/STAT1 peptidomimetics as anticancer drugsSEBTI SAID M·Filed 2009·Granted Apr 10, 2012·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when SEBTI SAID M files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →